Crystalline forms and salt forms of a kinase inhibitor

MYPI2025001655A0Undetermined Publication Date: 2020-06-13EXELIXIS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025001655
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-12-12
Filing Date
2019-12-12
Publication Date
2020-06-13
Patent Text Reader

Abstract

The present invention relates to crystalline forms of the free base of the c-Met inhibitor, Compound 1. The invention also relates to crystalline forms of salts of Compound 1. The invention also relates to pharmaceutical compositions comprising the solid polymorphs of the free base and salts of Compound 1. The invention further relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase.
Need to check novelty before this filing date? Find Prior Art